Patent Yard Sign in
Expired European patentEurope

Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis

EP 1068357 B1 · Applicant: NorthWest Biotherapeutics, Inc.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed March 29, 1999 and granted September 21, 2011. A European patent lasts at most 20 years from filing, so its term ended March 29, 2019.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 29, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 29, 1999
PublishedJanuary 17, 2001
GrantedSeptember 21, 2011
Term endedMarch 29, 2019
Application numberEP 99916365
Classification (CPC)C07K16/24 +2 more

Timeline

Timeline From EPO dates

2000200220042006200820102012201420162018Application filedMarch 29, 1999PublishedJan 17, 2001Patent grantedSep 21, 2011Term endedMarch 29, 2019

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.